Table 2 Active sites residues of LdmtPRI1 for docking against drug repurposing compounds.

From: Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

Residue number

Residue

148

Arginine

155

Glutamic acid

246

Asparagine

254

Lysine

259

Lysine

266

Valine

451

Asparagine

470

Cysteine

476

Threonine

477

Phenylalanine

481

Leucine